From: Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016–2017
E. coli (N = 9092) | K. pneumoniae (N = 3870) | A. baumannii (N = 3710) | P. aeruginosa (N = 3461) | Enterobacter spp. (N = 1322) | H. influenzae (N = 1085) | Salmonella spp. (N = 277) | Shigella spp. (N = 53) | |
---|---|---|---|---|---|---|---|---|
Carbapenem | 961/8830 (11%) | 1049/3816 (27%) | 2855/3622 (79%) | 1514/3376 (45%) | 376/1298 (29%) | 0/1065 (0%) | 1/195 (1%) | 1/19 (5%) |
Aminoglycosides | 4188/8785 (48%) | 1756/3780 (46%) | 2686/3641 (74%) | 1457/3389 (43%) | 637/1297 (49%) | 48/78 (62%) | 4/5 (80%) | |
Fluoroquinolones | 5813/8682 (67%) | 1593/3619 (44%) | 2929/3589 (82%) | 1435/3357 (43%) | 484/1271 (38%) | 7/909 (1%) | 18/253 (7%) | 7/46 (15%) |
Cephalosporins | 5441/8195 (66%) | 1995/3732 (53%) | 2969/3549 (84%) | 1392/3058 (46%) | 675/1192 (57%) | 18/664 (3%) | 20/217 (9%) | 8/26 (31%) |
Macrolides | 25/29 (86%) | 4/1015 (0%) | 53/137 (39%) | 2/3 (67%) | ||||
SXT | 5704/7843 (73%) | 1753/3348 (52%) | 1329/1388 (96%) | 467/929 (50%) | 429/470 (91%) | 39/237 (16%) | 44/50 (88%) | |
AMC | 1476/3251 (45%) | 1080/1999 (54%) | 461/604 (76%) | 271/358 (76%) | ||||
Ampicillin | 5547/5938 (93%) | 2563/2622 (98%) | 476/510 (93%) | 804/911 (88%) | 104/252 (41%) | 35/46 (76%) | ||
TCC | 1317/2947 (45%) | 863/1449 (60%) | 1097/2160 (51%) | 297/671 (44%) |